Fabrication, GSH-responsive drug release, and anticancer properties of thioctic acid-based intelligent hydrogels

Colloids Surf B Biointerfaces. 2022 Sep:217:112703. doi: 10.1016/j.colsurfb.2022.112703. Epub 2022 Jul 14.

Abstract

Injectable hydrogels are potential local drug delivery systems since they contain plenty of water and soft like biological tissues. Such hydrogels could be injected directly into the tumor site where the drug is released under the tumor microenvironment. However, drug loaded hydrogels for cancer treatment based on lipoic acid (natural small molecule) have not been exploited. Here, a novel poly(lipoic acid)-poly(ethylene glycol) (PEG-PTA) hydrogels were prepared through a two-step reaction. The hydrogels contained disulfide bonds, so they could be degraded via the thiol exchange reaction with the abundant GSH in the tumor microenvironment, and subsequently release the drug. The results in vitro and at cellular level showed that the hydrogels were degraded and released the drugs only in the presence of GSH. Therefore, the injectable GSH-responsive hydrogels are promising to be served as an intelligent drug delivery system for cancer treatment.

Keywords: Anticancer; GSH responsive release; Hydrogel; Thioctic acid.

MeSH terms

  • Drug Delivery Systems
  • Drug Liberation
  • Hydrogels* / chemistry
  • Polyethylene Glycols / chemistry
  • Thioctic Acid* / pharmacology

Substances

  • Hydrogels
  • Polyethylene Glycols
  • Thioctic Acid